NCT06489756View on ClinicalTrials.gov

Highlanders With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Arterial Pressure (PAP) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT)

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

High Altitude Pulmonary Hypertension

Interventions

OTHER

Echocardiography

Echocardiography will be performed according to clinical standards

Trial Locations (1)

Unknown

Aksay Medical Center, Aksay Plateau, Naryn, Kyrgyzstan

All Listed Sponsors

lead

University of Zurich

OTHER

NCT06489756 - Highlanders With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Arterial Pressure (PAP) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT) | Biotech Hunter | Biotech Hunter